Navigation Links
Frost & Sullivan Hosts Analyst Briefing: An Outlook of Azerbaijan and Iran Healthcare Markets
Date:7/25/2013

LONDON, July 25, 2013 /PRNewswire/ -- WHEN: 4pm BST on Thursday 1st August 2013 LOCATION: Online, with free registrationPRESENTERS: Healthcare Research Analysts Hilal Cura and Uldouz BerenjforoushWith their growing GDP and government's focus on reforms and development, Azerbaijan and Iran healthcare markets open up their doors to global companies and private investors, offering new opportunities across all segments, from the pharmaceutical field to the medical devices industry, as well as medical tourism.

Attend this webinar to:

  • Learn about the growth of Azerbaijan and Iran healthcare market
  • Identify the drivers and restraints
  • Discover trends across all market segments
  • This briefing will benefit global companies and private investors in the pharmaceutical, medical devices and medical services fields, by discussing current and emerging trends and providing forward-looking projections.

    Supporting Quotes"A young but rapidly growing oil-rich Azerbaijan presents itself as an untouched ground for investment. With its ever increasing GDP, we see healthcare expenditure following the same path as well. Azerbaijan has also gone through extensive reforms to ensure growth and development in its healthcare industry," notes Frost & Sullivan Research Analyst Hilal Cura.

    "A natural resource rich nation of over 75 million people - more than 50% of which under the age of 35 - Iran enjoys an enormous amount of wealth coming in from its oil & gas reservoirs. Its GDP is estimated to grow at an average of 2.4% over the next 10 years, offering interesting opportunities across all industries. Iran's healthcare industry was worth 26.44bn USD in 2011 and has grown to 28.13bn USD in 2012, up 6.4%," notes Frost & Sullivan Healthcare Research Analyst Uldouz Berenjforoush.

    Supporting ResourcesFor more information about Frost & Sullivan's Healthcare practice, please visit:

    http://www.frost.com/prod/servlet/svcg.pag/HC00

    Registration

  • To attend the briefing, email anna.zanchi@frost.com your full name, job title, company name, company telephone number, company email address and website, city, state and country.
  • Receive a recorded version of the briefing anytime by submitting the aforementioned contact details.
  • About Frost & SullivanFrost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

    Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
  • For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

    Contact Us:
    Start the discussion

    Join Us:
    Join our community

    Subscribe:
    Newsletter on "the next big thing"

    Register:
    Gain access to visionary innovation

    Contact
    Anna Zanchi
    Corporate Communications – Europe
    P: 0039 02 46514819
    E: anna.zanchi@frost.com
    http://www.frost.com


    '/>"/>
    SOURCE Frost & Sullivan
    Copyright©2012 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
    2. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
    3. European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
    4. Frost & Sullivan Research Preview: Top 20 Telehealth Markets
    5. Heightened Awareness, Coupled with Expanding Patient Pool, Stimulates Sleep Apnea Diagnostics and Sleep Services Market, Says Frost & Sullivan
    6. Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market
    7. MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan
    8. Frost & Sullivan: Developing Integration Capabilities Presents a Real Opportunity for Vendors in the European CIS Market
    9. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
    10. Electronic Medical Records Progress from an Enterprise-Centric Solution to a Customer-Specific Application, Finds Frost & Sullivan
    11. Frost & Sullivan to Host Complimentary Web Conference: Concerns and Solutions for the Anaesthesia Equipment and Associated Peripherals Market
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/29/2017)... DUBLIN , Mar. 29, 2017 ... "Intraoperative Neuromonitoring (IONM) Market Size & Forecast By Type (Insource ... - 2025" report to their offering. ... The global Intraoperative ... by 2025. The intraoperative neuromonitoring market is anticipated to witness ...
    (Date:3/29/2017)... March 29, 2017 Global intravenous (IV) iron and ... by 2021, growing at a CAGR of 5%. ... a doctor to treat anemia or other iron deficiencies. Oral ... the body. However, in some cases, oral administrations are not ... intravenous (IV) iron therapy comes into the picture. ...
    (Date:3/29/2017)... 29, 2017 Today, CVS Health officials (NYSE: ... , Department of Public Health Director Gerd Clabaugh ... in announcing the availability of the opioid overdose-reversal medicine ... Iowa.  CVS Health has established a standing order with physicians ... to expand access to the medication in the state.   ...
    Breaking Medicine Technology:
    (Date:3/30/2017)... Durham, NC (PRWEB) , ... March 30, 2017 ... ... professionals, will host the live audio conference “ Preventing Hospital Readmissions Through Discharge ... April 12, 2017 at 1:00 pm ET. This conference discusses strategies to prevent ...
    (Date:3/29/2017)... ... March 29, 2017 , ... In the United States alone, up ... year develop other types of metastatic brain tumors(3). Though most meningiomas are benign, metastatic ... focus on finding more effective treatment options, the San Diego Gamma Knife Center ...
    (Date:3/29/2017)... ... March 30, 2017 , ... CHARM CITY RUN WELCOMES MERCY MEDICAL CENTER AS ... Medical Center will serve as the official title sponsor of the Baltimore Women’s Classic, ... 2017, thousands of women will walk or run the course around the Baltimore Inner ...
    (Date:3/29/2017)... ... March 29, 2017 , ... Wells Pharmacy ... attending prescribers at the upcoming World Congress, in Hollywood Florida April 6-8, 2017. ... recognized as the visionary leader in the training of physicians, scientists, and members ...
    (Date:3/29/2017)... ... 29, 2017 , ... Patients interested in receiving quick and ... Jamie Cameron, with or without a referral. The FASTBRACES system is valued for ... each patient’s case, treatment with the FASTBRACES system could be completed in 120 ...
    Breaking Medicine News(10 mins):